# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001078782-17-000996
Filing Date
2017-07-24
Accepted
2017-07-24 16:16:59
Documents
6
Period of Report
2017-07-20
Effectiveness Date
2017-07-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINATIVE 14A PROXY STATEMENT | def14a071217_def14a.htm | DEF 14A | 492631
2 | IMAGE | def14a071217_def14a001.jpg | GRAPHIC | 135205
3 | IMAGE | def14a071217_def14a002.jpg | GRAPHIC | 215036
4 | IMAGE | def14a071217_def14a003.jpg | GRAPHIC | 90517
5 | IMAGE | def14a071217_def14a004.jpg | GRAPHIC | 237139
6 | IMAGE | def14a071217_def14a005.jpg | GRAPHIC | 626933
| Complete submission text file | 0001078782-17-000996.txt |  | 2285016

Mailing Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208
Business Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36833 | Film No.: 17978482
SIC: 2835 In Vitro & In Vivo Diagnostic Substances